Adial Pharmaceuticals, Inc.
ADIL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513525
In the last 90 days, Adial Pharmaceuticals, Inc. insiders filed 3 open-market purchases and 0 sales; 17 institutions reported holding it in 13F filings for Q2 2026, worth $334.6K in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Adial Pharmaceuticals, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- +7 vs. Q3 2025
- Shares held
- 3.54M
- +2.93M (+479.9%) vs. Q3 2025
- Total value
- $778.4K
- +$563.6K (+262.4%) vs. Q3 2025
- New holders
- 8
- 4 more added
- Sold out
- 1
- 4 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADIL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $334.6K |
| Q1 2026 | 15 | $63.8K |
| Q4 2025 | 24 | $778.4K |
| Q3 2025 | 17 | $214.8K |
| Q2 2025 | 17 | $70.8K |
| Q1 2025 | 14 | $152.7K |
| Q4 2024 | 15 | $298.1K |
| Q3 2024 | 12 | $195.9K |
| Q2 2024 | 16 | $328.0K |
| Q1 2024 | 16 | $236.2K |
| Q4 2023 | 17 | $495.3K |
| Q3 2023 | 11 | $164.2K |
| Q2 2023 | 21 | $488.2K |
| Q1 2023 | 23 | $876.9K |
| Q4 2022 | 23 | $359.2K |
| Q3 2022 | 28 | $692.1K |
| Q2 2022 | 26 | $2.27M |
| Q1 2022 | 23 | $6.38M |
| Q4 2021 | 24 | $3.61M |
| Q3 2021 | 21 | $5.50M |
| Q2 2021 | 19 | $3.15M |
| Q1 2021 | 20 | $1.95M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Adial Pharmaceuticals, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 2,554,442 | $562.0K | 0.01% | +2,554,442 | New |
| Citadel Advisors LLC | 219,621 | $48.3K | 0.00% | +75,830+52.7% | Added |
| Vanguard Group Inc | 156,024 | $34.3K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 155,745 | $34.3K | 0.00% | −8,382−5.1% | Reduced |
| Jane Street Group, LLC | 121,841 | $26.8K | 0.00% | +109,500+887.3% | Added |
| Northern Trust Corp | 65,979 | $14.5K | 0.00% | +65,979 | New |
| Virtu Financial LLC | 63,827 | $14.0K | 0.00% | +63,827 | New |
| XTX Topco Ltd | 52,097 | $11.5K | 0.00% | +52,097 | New |
| Manchester Capital Management LLC | 48,097 | $10.6K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 27,770 | $6.11K | 0.00% | 00.0% | Unchanged |
| StoneX Group Inc. | 19,451 | $4.28K | 0.00% | +19,451 | New |
| Two Sigma Securities, LLC | 17,074 | $3.76K | 0.00% | +4,233+33.0% | Added |
| Susquehanna International Group, LLP | 12,087 | $2.66K | 0.00% | +12,087 | New |
| Private Management Group Inc | 10,000 | $2.20K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 9,167 | $2.02K | 0.00% | −9,591−51.1% | Reduced |
| Raffa Wealth Management, LLC | 2,093 | $460 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,341 | $295 | 0.00% | −29−2.1% | Reduced |
| SBI Securities Co., Ltd. | 1,158 | $255 | 0.00% | −238−17.0% | Reduced |
| Bank of America Corp | 205 | $45 | 0.00% | +23+12.6% | Added |
| Wells Fargo & Company | 160 | $35 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 99 | $22 | 0.00% | +99 | New |
| Abound Wealth Management | 27 | $6 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 9 | $2 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1 | $0 | 0.00% | +1 | New |
| HRT Financial LP | 0 | $0 | 0.00% | −11,191−100.0% | Sold out |